These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22531886)
1. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier. Li Z; Liu YH; Xue YX; Liu LB; Wang P J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886 [TBL] [Abstract][Full Text] [Related]
2. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism. Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443 [TBL] [Abstract][Full Text] [Related]
3. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway. Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255 [TBL] [Abstract][Full Text] [Related]
4. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier. Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743 [TBL] [Abstract][Full Text] [Related]
5. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB. Xie H; Xue YX; Liu LB; Liu YH; Wang P J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708 [TBL] [Abstract][Full Text] [Related]
6. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway. Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039 [TBL] [Abstract][Full Text] [Related]
7. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier. Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651 [TBL] [Abstract][Full Text] [Related]
8. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway. Li Z; Liu YH; Xue YX; Liu LB; Wang P J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier. Li Z; Liu YH; Xue YX; Liu LB; Xie H J Mol Neurosci; 2012 Jun; 47(2):408-17. PubMed ID: 21969114 [TBL] [Abstract][Full Text] [Related]
10. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier. Li Z; Liu YH; Xue YX; Xie H; Liu LB J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144 [TBL] [Abstract][Full Text] [Related]
11. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins. Xie H; Xue YX; Liu LB; Liu YH Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091 [TBL] [Abstract][Full Text] [Related]
12. Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier. Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Yao YL; Ma J J Mol Neurosci; 2015 Sep; 57(1):1-10. PubMed ID: 26044663 [TBL] [Abstract][Full Text] [Related]
13. PKC and RhoA signals cross-talk in Escherichia coli endotoxin induced alterations in brain endothelial permeability. He F; Yin F; Omran A; Yang LF; Xiang QL; Peng J Biochem Biophys Res Commun; 2012 Aug; 425(2):182-8. PubMed ID: 22846579 [TBL] [Abstract][Full Text] [Related]
14. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma. Zhang Z; Xue Y; Liu Y; Shang X Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613 [TBL] [Abstract][Full Text] [Related]
15. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase. Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438 [TBL] [Abstract][Full Text] [Related]
16. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway. Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310 [TBL] [Abstract][Full Text] [Related]
17. The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier. Liu J; Liu L; Chao S; Liu Y; Liu X; Zheng J; Chen J; Gong W; Teng H; Li Z; Wang P; Xue Y Front Cell Neurosci; 2017; 11():358. PubMed ID: 29311822 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C-α signals P115RhoGEF phosphorylation and RhoA activation in TNF-α-induced mouse brain microvascular endothelial cell barrier dysfunction. Peng J; He F; Zhang C; Deng X; Yin F J Neuroinflammation; 2011 Apr; 8():28. PubMed ID: 21473788 [TBL] [Abstract][Full Text] [Related]
19. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway. Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803 [TBL] [Abstract][Full Text] [Related]
20. PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway. Srivastava K; Shao B; Bayraktutan U J Cereb Blood Flow Metab; 2013 Dec; 33(12):1928-36. PubMed ID: 23963366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]